Ticker
LYRACompany Name
LYRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 52.57M | $ 770K | 1.46% |
3/31/2025 | $ 56.32M | $ 1.19M | 2.1% |
12/31/2024 | $ 66.35M | $ 1.53M | 2.31% |
9/30/2024 | $ 78.76M | $ 1.47M | 1.87% |
6/30/2024 | $ 94.58M | $ 1.82M | 1.92% |
3/31/2024 | $ 141.53M | $ 1.68M | 1.19% |
12/31/2023 | $ 142.6M | $ 1.56M | 1.09% |
9/30/2023 | $ 120.58M | $ 1.42M | 1.18% |
6/30/2023 | $ 125.67M | $ 1.24M | 0.99% |
3/31/2023 | $ 93.87M | $ 1.3M | 1.39% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for LYRA THERAPEUTICS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 87.33M ]
(=) GPA [ 0% ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 84.08% |
average | 20.16% |
median | 15.34% |
std | 19.94% |